Effect of the leukotriene receptor antagonist MK-0679 on baseline pulmonary function in aspirin sensitive asthmatic subjects

Dahlén, B; Margolskee, D J; Zetterström, O; Dahlén, S E
December 1993
Thorax;Dec1993, Vol. 48 Issue 12, p1205
Academic Journal
No abstract available.


Related Articles

  • A risk-benefit assessment of antileukotrienes in asthma. Smith, L.J. // Drug Safety;Sep1998, Vol. 19 Issue 3, p205 

    The antileukotriene drugs are the first new therapeutic agents approved for the treatment of asthma in more than 20 years. The currently available compounds are orally active and either prevent the cysteinyl leukotrienes from binding to and activating the cysLT-1 receptor in the lung...

  • Leukotriene modifiers in the treatment of asthma. Sampson, Anthony; Holgate, Stephen // BMJ: British Medical Journal (International Edition);04/25/98, Vol. 316 Issue 7140, p1257 

    Editorial. Looks at the treatment of asthma with the use of leukotriene modifiers. Reference to leukotriene synthesis inhibitors and cysteinyl leukotriene receptor antagonists, which are the two types of leukotriene modifiers; Detailed information on the two leukotriene modifiers; Relation to...

  • Evaluation of Theophylline or Pranlukast, a Cysteinyl Leukotriene Receptor 1 Antagonist, as Add-On Therapy in Uncontrolled Asthmatic Patients with a Medium Dose of Inhaled Corticosteroids. Tsuchida, Tomoko; Matsuse, Hiroto; Machida, Ikuko; Kondo, Yuki; Saeki, Sachiko; Tomari, Shinya; Obase, Yasushi; Matsuo, Nobuko; Shimoda, Terufumi; Kohno, Shigeru // Allergy & Asthma Proceedings;Jul/Aug2005, Vol. 26 Issue 4, p287 

    A few studies compared the additional effects of oral controller medicines on pulmonary function in asthmatic patients on a moderate dose of inhaled steroids. The aim of this study was to compare the additional effects of two oral asthma controllers, a leukotriene receptor antagonist and a...

  • Leukotrienes, Antileukotrienes and Asthma. Montuschi, Paolo // Mini Reviews in Medicinal Chemistry;Jun2008, Vol. 8 Issue 7, p647 

    Leukotrienes (LTs), including LTB4 and cysteinyl-LTs (CysLTs) (LTC4, LTD4, and LTE4), are potent inflammatory lipid mediators which are derived from 5--lipoxygenase activity. CysLTs, which stimulate CysLT1 and CysLT2 receptor subtypes, are functionally involved in the pathophysiology of asthma....

  • Randomised, placebo controlled trial of effect of a leukotriene receptor antagonist, montelukast, on tapering inhaled corticosteroids in asthmatic patients. Lofdahl, Claes-Goran // BMJ: British Medical Journal (International Edition);07/10/99, Vol. 319 Issue 7202, p87 

    Presents information on a study on the ability of montelukast, a leukotriene receptor antagonist, to allow tapering of inhaled corticosteroids in clinically stable asthmatic patients. Participants and methods; Results; Conclusions.

  • Leukotriene Receptors and Aspirin Sensitivity. Arm, Jonathan P.; Austen, K. Frank // New England Journal of Medicine;11/7/2002, Vol. 347 Issue 19, p1524 

    Editorial. Argues that a study by Sousa et al. provides insight into the abnormalities of cysteinyl luekotiene pathways in aspirin-sensitive asthma. Increased basal biosynthesis of the cysteinyl leukotrienes in aspirin-sensitive asthma; How disregulation of the receptors for the cysteinyl...

  • Intracerebroventricular injection of leukotriene B4 attenuates antigen-induced asthmatic response via BLT1 receptor stimulating HPA-axis in sensitized rats. Shui-Juan Zhang; Yang-Mei Deng; Yi-Liang Zhu; Xin-Wei Dong; Jun-Xia Jiang; Qiang-Min Xie // Respiratory Research;2010, Vol. 11, p39 

    Background: Basic and clinical studies suggest that hypothalamic-pituitary-adrenal (HPA) axis is the neuroendocrineimmnue pathway that functionally regulates the chronic inflammatory disease including asthma. Our previous studies showed corresponding changes of cytokines and leukotriene B4...

  • leukotriene receptor antagonists. Peters, Michael // BMA A-Z Family Medical Encyclopedia;2004, p466 

    An encyclopedia entry for "leukotriene receptor antagonists" is presented. It refers to a group of antiallergy drugs administered to prevent the symptoms of mild to moderate asthma. Leukotriene receptor antagonists work by blocking the effects of leukotrienes. Adverse events associated with...

  • New Insights into the Molecular Mechanisms of Corticosteroids Actions. Adcock, Ian M.; Caramori, Gaetano; Ito, Kazuhiro // Current Drug Targets;Jun2006, Vol. 7 Issue 6, p649 

    Corticosteroids produce a marked improvement in clinical parameters in most asthmatic patients; in contrast, corticosteroids have little effect on lung function measurements in patients with chronic obstructive pulmonary disease. By uncovering the reason for this paradox, it should be possible...

  • Leukotriene-Receptor Expression on Nasal Mucosal Inflammatory Cells in Aspirin-Sensitive Rhinosinusitis. Sousa, Ana R.; Parikh, Abhi; Scadding, Glenis; Corrigan, Christopher J.; Lee, Tak H. // New England Journal of Medicine;11/7/2002, Vol. 347 Issue 19, p1493 

    Background: Patients with asthma who have aspirin sensitivity have greater cysteinyl leukotriene production and greater airway hyperresponsiveness to the effects of inhaled cysteinyl leukotrienes than their aspirin-tolerant counterparts. We hypothesized that the latter effect reflects elevated...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics